CERUS CORP (CERS)
US1570851014 - Common Stock
Cerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024
Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors
Cerus Corporation Celebrates World Blood Donor Day 2024
Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference
CERS Stock Earnings: Cerus Meets EPS, Misses Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cerus (NASDAQ:CERS) just reported results for the first quarter of 2024.Cerus r...
CERS Stock Earnings: Cerus Meets EPS, Misses Revenue for Q1 2024
CERS stock results show that Cerus met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Cerus Corporation Announces First Quarter 2024 Financial Results
Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024
Commit To Purchase Cerus At $1, Earn 32.6% Annualized Using Options
CERS Stock Earnings: Cerus Beats EPS, Misses Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cerus (NASDAQ:CERS) just reported results for the fourth quarter of 2023.Cerus ...
CERS Stock Earnings: Cerus Beats EPS, Misses Revenue for Q4 2023
CERS stock results show that Cerus beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024
Cerus Corporation to Participate in Upcoming Investor Conferences
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The widely followed growth investor keeps making moves.
Cantor picks RCEL as best 2024 medtech idea; bullish on PACB, AXGN, CERS
Cantor Fitzgerald picks AVITA Medical (RCEL) as its best 2024 medtech idea, while remaining bullish on AXGN, CERS, ELUT, XGN, NNOX, NPCE, NYXH, SIBN, and PACB. Read more here.
3 Growth Stocks That Could Go Parabolic in 2024
These innovation-oriented companies could take flight this year.
Cerus says preliminary product revenue for Q4 totaled $46.8M (NASDAQ:CERS)
Cerus Corporation reports 6% increase in fourth-quarter product revenue. Full-year unaudited revenue for 2023 expected to be $156.4 million.
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update